Filing metadata

Accession number
0001127602-23-026081
Form type
Form 4
Filer
Apellis Pharmaceuticals, Inc.
CIK
CIK 1492422
Filed
Oct 18, 2023
Reporting period
Oct 17, 2023
Description
Insider transaction

Explore SEC Filings Hub